Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	12.2	13.72	12.66	5.84	23.24
Short-Term Investments	60.92	45.88	69.13	98.69	8.08
Cash & Short-Term Investments	73.13	59.6	81.79	104.53	31.32
Cash Growth	22.70%	-27.13%	-21.76%	233.79%	-31.94%
Other Current Assets	5.17	4.63	3.97	1.95	1.33
Total Current Assets	78.3	64.23	85.76	106.48	32.64
Net Property, Plant & Equipment	26.88	21.54	21.16	13.28	7.55
Other Long-Term Assets	0.48	0.43	0.47	0.39	2.03
Total Assets	105.65	86.2	107.39	120.15	42.22
Accounts Payable	3.87	3.53	2.57	1.42	1.2
Accrued Expenses	5.51	4.13	3.47	2.25	3.2
Current Portion of Leases	1.13	1.01	1.06	0.67	-
Total Current Liabilities	10.51	8.68	7.1	4.34	4.41
Long-Term Debt	6.35	5.56	5.61	-	-
Long-Term Leases	6.24	5.96	6.6	4.52	-
Other Long-Term Liabilities	5.45	3.34	3.6	5.63	18.62
Total Long-Term Liabilities	18.05	14.86	15.81	10.15	18.62
Total Liabilities	28.55	23.54	22.91	14.49	23.03
Minority Interest	-	-	-	-	53.96
Shareholders' Equity	77.1	62.67	84.48	105.66	19.19
Total Liabilities & Equity	105.65	86.2	107.39	120.15	42.22
Total Debt	13.73	12.54	13.28	5.19	0
Net Cash (Debt)	59.4	47.06	68.51	99.34	31.32
Net Cash Growth	26.21%	-31.30%	-31.03%	217.21%	-31.94%
Net Cash Per Share	0.74	0.67	0.99	1.56	0.77

Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q